| Literature DB >> 28197414 |
Carlos F Araujo-Lima1, Rafael J M Nunes1, Raphael M Carpes1, Claudia A F Aiub2, Israel Felzenszwalb1.
Abstract
Sclerosing agents as zinc gluconate-based chemical sterilants (Infertile®) are used for chemical castration. This solution is injected into the animal testis, but there are not enough evidences of its safety profiles for the receivers. The present work aimed to establish the pharmacokinetics and toxicological activity of Infertile, using in vitro and in silico approaches. The evaluation at the endpoint showed effects in a dose-dependent manner. Since necrosis is potentially carcinogenic, the possible cell death mechanism could be apoptosis. Our data suggested that Infertile at 60 mM presented risk for animal health. Even though Infertile is a licensed product by the Brazilian Ministry of Agriculture, Livestock and Supply, it presented a high mutagenic potential. We suggest that the optimal dose must be less than 6 mM, once, at this concentration, no mutagenicity or genotoxicity was observed.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28197414 PMCID: PMC5288521 DOI: 10.1155/2017/5746768
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Zinc gluconate chemical structure.
Infertile's pharmacokinetic (ADME) properties prediction in pkCSM analysis of similarity.
| Property | Model name | Predicted value | Unit |
|---|---|---|---|
| Absorption | Water solubility | 2.99 | Numeric (mmol/L) |
| Absorption | Caco2 permeability | −0,8980 | Numeric (log Papp in 10−6 cm/s) |
| Absorption | Intestinal absorption (human) | 0,0000 | Numeric (% Absorbed) |
| Absorption | Skin permeability | −2.7350 | Numeric (log Kp) |
| Absorption | P-glycoprotein substrate | Yes | Categorical (yes/no) |
| Absorption | P-glycoprotein I inhibitor | No | Categorical (yes/no) |
| Absorption | P-glycoprotein II inhibitor | No | Categorical (yes/no) |
| Distribution | VDss (human) | 44.9 | Numeric (mL/kg) |
| Distribution | Fraction unbound (human) | 0.8810 | Numeric (Fu) |
| Distribution | BBB permeability | −2.2160 | Numeric (log BB) |
| Distribution | CNS permeability | −6.1620 | Numeric (log PS) |
| Metabolism | CYP2D6 substrate | No | Categorical (yes/no) |
| Metabolism | CYP3A4 substrate | No | Categorical (yes/no) |
| Metabolism | CYP1A2 inhibitor | No | Categorical (yes/no) |
| Metabolism | CYP2C19 inhibitor | No | Categorical (yes/no) |
| Metabolism | CYP2C9 inhibitor | No | Categorical (yes/no) |
| Metabolism | CYP2D6 inhibitor | No | Categorical (yes/no) |
| Metabolism | CYP3A4 inhibitor | No | Categorical (yes/no) |
| Excretion | Total clearance | 4.06 | Numeric (ml/min/kg) |
| Excretion | Renal OCT2 substrate | No | Categorical (yes/no) |
VDss: volume of distribution at steady state; BBB: brain blood barrier; CNS: central nervous center; CYP: cytochrome P; OCT: organic cation transporter.
Comparison between pKCSM and LAZAR toxicity prediction of Infertile.
| Model Name | pkCSM | LAZAR | ||
|---|---|---|---|---|
| Unit | Prediction | Unit | Prediction | |
| AMES toxicity | Categorical (yes/no) | No | Categorical (yes/no) | No |
| Hepatotoxicity | Categorical (yes/no) | No | n.a. | — |
| Skin sensitisation | Categorical (yes/no) | No | n.a. | — |
| hERG I inhibitor | Categorical (yes/no) | No | n.a. | — |
| hERG II inhibitor | Categorical (yes/no) | No | n.a. | — |
| Oral rat acute toxicity (LD50) | Numeric (mol/kg) | 0.29 | n.a. | — |
| Oral rat chronic toxicity (LOAEL) | Numeric (mg/kg/day) | 22.49 | n.a. | — |
| Carcinogenicity (rat) | n.a. | — | Categorical (Yes/No) | Yes |
| Carcinogenicity (mouse) | n.a. | — | Categorical (Yes/No) | Yes |
| Carcinogenicity (rodents) | n.a. | — | Categorical (Yes/No) | Yes |
| Max. tolerated dose (human) | Numeric (mg/kg/day) | 16.11 | Numeric (mg/kg/day) | 7.93 |
|
| Numeric (log ug/L) | 1.93 | n.a. | — |
| Fathead minnow toxicity | Numeric (mol/L) | 1,164 | Numeric (mol/L) | 1,567 |
hERG: human Ether-à-go-go-Related Gene; LD50: lethal dose of 50%; LOAEL: lowest observed adverse effect level; n.a.: not analyzed.
Figure 2Mutagenicity and cytotoxicity evaluation of Infertile. The graphs ((a), (b), (c), and (d)) show that, in both absence (−S9, ●) and presence (+S9, ▲) of exogenous metabolism, there were no mutagenic concentrations to TA97, TA100, TA102, and TA104. On the other hand, in (e), mutagenic activity to TA98 (−S9) was detected. No cytotoxic (survival ≤ 70%) response was observed to TA97, TA98, and TA100 (−S9/+S9, data not shown). In (f), there was a decrease of survival to TA102 and TA104 at 60 mM ( < 0.01 versus negative control; n = 3 in triplicate; one-way ANOVA followed by Tukey's post hoc test).
Figure 3Infertile genotoxicity and cytotoxicity evaluation using RAW267.4 macrophage cell lineage. There are three curves showing the percentage of micronucleated cells (MN) in apoptosis (Apo) and necrosis (Nec). It can be observed that, at 12 mM, there is predominance of micronucleated cells (85/1000 cells), at 30 mM, cells in apoptosis predominate (143/1000 cells) and, at 60 mM of Infertile, there were 318 cells in necrosis/1000. It is important to note that when an event prevails, others tend to diminish. It is possible to observe that there is a turnover among the cell death events ( < 0.01 versus negative control; n = 3 in triplicate; one-way ANOVA followed by Tukey's post hoc test).